Research and clinical trials

Research into eosinophilic asthma is expanding. Eosinophilic asthma is sometimes also called eos asthma, e-asthma, or type 2 asthma. Some areas of study include:

Immune system.

A better understanding of the immune system’s role in eos asthma could help scientists develop treatments.

Genetic factors.

The genes involved with eos asthma can help provide clues as to how the condition might be prevented.

Biomarkers.

Biomarkers are molecules such as genes, hormones or proteins. These can help doctors diagnose a disease. High counts of eosinophils in the blood are one possible biomarker for eos asthma. Biomarkers can help us predict which treatments might be more effective for a person who has eos asthma.

Scientists working in lab on treatments for eos asthma

Clinical trials

Clinical trials for eos asthma are currently underway. Many of these studies focus on new medicines to control asthma symptoms.

There are many advantages to participating in a trial. One advantage is that you receive medical care from providers experienced with the condition. You also might have the chance to try new medicines that are being developed.

Studies enrolling for eosinophilic asthma are posted to ClinicalTrials.gov.

Black woman at the doctor. He is explaining eos asthma to her.

Thin, middle aged woman with short hair coughing into her hand. The doctor is standing behind her holding a stethoscope to the back of her lungs.

Woman doctor holding a stethoscope to a tween girl. They are in her office and both of them are smiling.

Young adult woman at the doctors. She's holding her chest with one hand and they are talking about eos asthma diagnosis.